Previous Close | 1.4400 |
Open | 1.4300 |
Bid | 1.4000 x 1000 |
Ask | 1.4700 x 1200 |
Day's Range | 1.3800 - 1.4400 |
52 Week Range | 1.0400 - 3.2300 |
Volume | |
Avg. Volume | 359,819 |
Market Cap | 75.571M |
Beta (5Y Monthly) | 1.23 |
PE Ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings Date | N/A |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | Aug 28, 1996 |
1y Target Est | N/A |
VIENNA, Va., May 16, 2024--CEL-SCI Corporation reports second quarter fiscal 2024 financial results.
VIENNA, Va., May 08, 2024--CEL-SCI receives FDA go-ahead for its confirmatory study of Multikine in the treatment of head & neck cancer.
VIENNA, Va., April 23, 2024--CEL-SCI appoints Mario Gobbo to its Board of Directors.